Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2025-12-25 @ 8:18 PM
NCT ID:
NCT00267969
Group ID:
EG003
Title:
Placebo -> Ustekinumab 45 mg (After CP)
Description:
After Controlled period (Week 12-264) - patients receiving Placebo at Weeks 0 and 4 -\> receiving ustekinumab 45 mg every 12 weeks (q12wk) or every 8 weeks (q8wk) from Week 12 to Week 244. Some patients were withdrawn from ustekinumab at Week 40 and re-treated with ustekinumab 45 q12w.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
20
Serious Number At Risk:
123
Other Number Affected:
110
Other Number At Risk:
123
Study:
NCT00267969
Results Section:
NCT00267969
Adverse Events Module:
NCT00267969